In almost 40 years with Fitzpatrick, Henry has amassed expertise in litigating complex patent infringement cases in the federal courts, including in the district courts and the Court of Appeals for the Federal Circuit. He has been lead counsel for many clients and has been trial counsel for many others.
Mr. Renk was formerly an adjunct Professor of Law at Pace University School of Law in White Plains, New York, where he taught Patent Law.
AstraZeneca Pharms. LP, et al. v. Anchen Pharms, Inc., et al.
Fed. Cir. (2013)
Lead counsel in a successful patent infringement trial for AstraZeneca against a number of generic drug companies regarding AstraZeneca's patent covering its very successful Seroquel XR® antipsychotic drug, and he led a team in the Federal Circuit that obtained a per curiam affirmance of the district court judgment. Earlier, Mr. Renk was lead counsel for AstraZeneca in a patent infringement case against generic drug companies involving AstraZeneca's patent protecting its blockbuster Seroquel® antipsychotic drug. A district court summary judgment in AstraZeneca's favor was affirmed on appeal.